| 000 | 01824 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514214727.0 | ||
| 264 | 0 | _c20050301 | |
| 008 | 200503s 0 0 eng d | ||
| 022 | _a0002-9270 | ||
| 024 | 7 |
_a10.1111/j.1572-0241.2005.40757.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBalan, Vijayan | |
| 245 | 0 | 0 |
_aErythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ribavirin. _h[electronic resource] |
| 260 |
_bThe American journal of gastroenterology _cFeb 2005 |
||
| 300 |
_a299-307 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnemia _xblood |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aErythropoietin _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemoglobins _xanalysis |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolyethylene Glycols |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
| 700 | 1 | _aSchwartz, David | |
| 700 | 1 | _aWu, George Y | |
| 700 | 1 | _aMuir, Andrew J | |
| 700 | 1 | _aGhalib, Reem | |
| 700 | 1 | _aJackson, John | |
| 700 | 1 | _aKeeffe, Emmet B | |
| 700 | 1 | _aRossaro, Lorenzo | |
| 700 | 1 | _aBurnett, Alfreda | |
| 700 | 1 | _aGoon, Betty L | |
| 700 | 1 | _aBowers, Peter J | |
| 700 | 1 | _aLeitz, Gerhard J | |
| 773 | 0 |
_tThe American journal of gastroenterology _gvol. 100 _gno. 2 _gp. 299-307 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1572-0241.2005.40757.x _zAvailable from publisher's website |
| 999 |
_c15346025 _d15346025 |
||